GSK and Spero Therapeutics' oral cabapenem, tebipenem HBr, has become the first antibiotic in the class to show efficacy in a phase 3 trial involving patients with complicated urinary tract infections ...

Patient safety is a mindset that begins on day one and grows with every child. It is not confined to hospitals, it extends ...

As someone with a sound scientific background, immersed in the technical side of this work, I’ve seen firsthand how the field ...

Roche's Japanese unit Chugai Pharma has reached a deal to buy Renalys Pharma, a company set up to bring therapies developed elsewhere to markets in Asia. Chugai is paying JP 15 billion ($98 million) ...

AstraZeneca has breached the UK pharma industry's code of practice with a claim on its website for asthma drug Symbicort, ...

The Nubeqa (darolutamide) regimen can be used to treat adult patients with advanced HSPC if docetaxel, a chemotherapy agent, ...

Poolbeg Pharma Plc is a clinical-stage biopharmaceutical company with a core focus on transforming the cancer immunotherapy ...

A new report from the Institute for Clinical and Economic Review (ICER) in the US has found that the net prices of newly ...

Against the odds, GSK has secured FDA approval for its multiple myeloma therapy Blenrep, three years after it was removed ...

Ipsen has reached an agreement to buy fellow French firm ImCheck Therapeutics in a deal that could be worth up to €1 billion ($1.16 billion), adding an antibody-based therapy for acute myeloid ...

Johnny Cheng, currently CFO of HUTCHMED, has been named acting CEO following the departure of Dr Weiguo Su due to health ...

Pharma has three choices when it comes to AI for patient experience: Resist it. Try to control patient-led innovation through ...